GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Innophos Holdings Inc (NAS:IPHS) » Definitions » EBITDA Margin %

Innophos Holdings (Innophos Holdings) EBITDA Margin % : 12.87% (As of Sep. 2019)


View and export this data going back to 2006. Start your Free Trial

What is Innophos Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Innophos Holdings's EBITDA for the three months ended in Sep. 2019 was $24.4 Mil. Innophos Holdings's Revenue for the three months ended in Sep. 2019 was $189.3 Mil. Therefore, Innophos Holdings's EBITDA margin for the quarter that ended in Sep. 2019 was 12.87%.


Innophos Holdings EBITDA Margin % Historical Data

The historical data trend for Innophos Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innophos Holdings EBITDA Margin % Chart

Innophos Holdings Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.29 10.85 15.83 14.37 12.64

Innophos Holdings Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.09 12.11 13.42 14.15 12.87

Competitive Comparison of Innophos Holdings's EBITDA Margin %

For the Specialty Chemicals subindustry, Innophos Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innophos Holdings's EBITDA Margin % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Innophos Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Innophos Holdings's EBITDA Margin % falls into.



Innophos Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Innophos Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2018 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2018 )/Revenue (A: Dec. 2018 )
=101.331/801.842
=12.64 %

Innophos Holdings's EBITDA Margin % for the quarter that ended in Sep. 2019 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2019 )/Revenue (Q: Sep. 2019 )
=24.367/189.349
=12.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innophos Holdings  (NAS:IPHS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Innophos Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Innophos Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Innophos Holdings (Innophos Holdings) Business Description

Traded in Other Exchanges
N/A
Address
259 Prospect Plains Road, Cranbury, NJ, USA, 08512
Innophos Holdings Inc is a holding company that manufactures and sells through its subsidiaries a variety of ingredients used in the production of food, beverages, dietary supplements, pharmaceuticals, and oral care products. Innophos ingredients are made primarily from specialty phosphates. The company organizes itself into three segments namely Food, Health and Nutrition; Industrial Specialties and Other. The Food, Health and Nutrition segment contribute the maximum revenue. The company operates in U.S., Canada, Mexico and other countries.
Executives
John M Steitz director ALBEMARLE CORP, 451 FLORIDA ST, BATON ROUGE LA 70801
Kim Ann Mink director, officer: Chairman, CEO, President 259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
Gary A Cappeline director 50 E RIVERCENTER BLVD, COVINGTON KY 41012
Karen R Osar director C/O WESTVACO CORP, ONE HIGH RIDGE PARK, STAMFORD CT 06905
Mark Santangelo officer: Sr. VP, Mfg, Eng & EH&S 15710 JOHN F. KENNEDY BLVD., SUITE 300 HOUSTON TX 77032
Peter T Thomas director 1000 LAKESIDE AVENUE, CLEVELAND OH 44114
Hermanus Kieftenbeld officer: Senior VP and CFO 259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
James P. Zallie director 5 WESTBROOK CORPORATE CENTER, WESTCHESTER IL 60154
Randy Gress director, officer: CEO 259 PROSPECT PLAINS ROAD, P O BOX 8000, CRANBURY NJ 08512-8000
Stephen M Zide director BAIN CAPITAL PARTNERS, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Richard Heyse officer: VP-Chief Financial Officer 259 PROSPECT PLAINS ROAD, BUILDING G, P O BOX 8000, CRANBURY NJ 08512-8000
Bain Capital Investors Llc 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Partners Vii Lp 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Llc 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Vii Lp 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116

Innophos Holdings (Innophos Holdings) Headlines

From GuruFocus

INNOPHOS HOLDINGS, INC. (IPHS) CEO Randy Gress sells 20,000 Shares

By GuruFocus Research GuruFocus Editor 08-18-2010

INNOPHOS HOLDINGS, INC. (IPHS) CEO Randy Gress sells 20,000 Shares

By GuruFocus Research GuruFocus Editor 09-17-2010